China Universal Asset Management Co., Ltd. Verve Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,952 shares of VERV stock, worth $154,925. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,952
Previous 16,276
10.3%
Holding current value
$154,925
Previous $78,000
29.49%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding VERV
# of Institutions
180Shares Held
73.3MCall Options Held
85KPut Options Held
215K-
Alphabet Inc. Mountain View, CA12.3MShares$107 Million4.09% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$57.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.96MShares$42.8 Million0.01% of portfolio
-
State Street Corp Boston, MA4.25MShares$36.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$34.6 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $517M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...